Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Expert insights reveal how 3D cellular models are revolutionising preclinical testing and clinical translation.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...